Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

By Gillian D. Sanders, A. Bayoumi, V. Sundaram, S. P. Bilir, Christopher P. Neukermans, C. Rydzak, L. R. Douglass, Laura Lazzeroni, Mark Holodniy, D. Owens. New England Journal of Medicine, 2005

638 citations recorded by the source corpus.

Subfields: Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/35b3c2e601f40185f90911f722f56d99cf7275c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Abdur Rais
2. Ana Viana

Citations in the corpus

• Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. (2006, neutral): “, hypertension, colon cancer, and breast cancer) (27,86).”
• Operations Research in Healthcare: a survey (2011, methodology): “Sanders et al. (2005) used a Markov model of costs, quality of life and survival associated with a HIV-screening programme to analyse benefits and effectiveness of screening for HIV during the highly active antiretroviral therapy.”